Medic Bleep is a secure and real-time communication solution that aims to help medical teams communicate and collaborate effectively, reduce costs, and improve patient outcomes. It argues that poor inter-team communication has led to an estimated 400,000 episodes of potential harm a year, in the National Health Service (NHS) alone. Medic Bleep aspires to change this. It points out that its services have saved an average of £2.5 million worth of potential harm expenses per NHS Trust. The company asserts that its services are now being used by 5,600+ staff across hospitals every month. Medic Bleep has partnered with the BT Group targeting 20% of NHS trusts by 2025. It has 5,600 monthly active users and has witnessed 18,000 app downloads on multiple platforms. The company will use the investment to develop Version 2 of its product, deliver on its BT contract and NHS X framework to increase sales, and explore other geographies.
days to go:
Expired
investment:
£455,375
Zone V makes the latest tablets and smartphones work for the older generation with low eyesight, deficient hearing or dexterity. The company has redefined a global platform that is providing access to the services that are difficult to use. They have a technological partnership with Samsung and are a Samsung Managed Solutions Partner. The company also creates inclusively accessible technology, services, and applications for more smoother and viable communication. The executive team of this company includes health, telecoms, and wellness fields. With the proceeds, Zone V will widen the digital divide for the older smartphones users by working tirelessly to build new innovative communication solutions.
days to go:
Expired
investment:
£500,000
Gendius is a company that aims to bring pharmaceuticals and health economics, through clinical research and evidence, to the mobile health market. Their latest innovation, Intellin, is an intelligent remote management diabetes platform, with over 140,000 downloads so far. The COVID-19 crisis has highlighted the need for remote home monitoring of patients, and the company feels that its product is a suitable contender in this domain. Intellin has a reliable connection to over 150 medical devices and apps, and also consists of a two-way communication setup with a healthcare professional via a secure dashboard. Gendius is registered as an approved vendor with AstraZeneca in Saudi Arabia and looks to establish deeper relations with the National Health Service (UK) to create a demand for its product. The company will use the investment to scale its business globally, drive commercialisation, offer an opportunity to its stakeholders, and target venture capital.
days to go:
Expired
investment:
£386,829
Carbon Gold (CG) is an organic biochar producer and retailer. It claims that its products can replace harmful pesticides, last longer, and lock away CO2. The company's sales increased by 253% from £77,000 to £272,000 in 2020 with sales in 17 countries worldwide. CG's organic products employ biochar, a type of charcoal made from sustainably sourced materials. CG further enriches it with multiple strains of fungi, bacteria and minerals, that support healthy soil biology. The company is partnering with the Woodland Trust, is certified by the Soil Association, and is also a certified B Corp. The company will use the investment to boost its marketing, international development, and manufacturing.
days to go:
Expired
investment:
£722,468
TiPJAR is a cashless and contactless tipping platform that allows guests to tip workers in under 8 seconds via their phones, with no app required. TiPJAR's distribution engine empowers staff to control and share their tips and takes the admin burden and risk away from business owners. The company estimates the global tipping market to be worth a combined $100 billion per year, and it aims to be the worlds first multi-currency, scalable solution in this segment. The company's clients include Honest Burger, Yard Sale Pizza, and BrewDog. TiPJAR will use the investment to have live clients by November 2020 and expand across Europe and Australia.
days to go:
Expired
investment:
£699,748
True Royalty Television is the first and only established TV channel serving the global millions of Royal super-fans, with 20,000 paying subscribers already on its platform. The British Royal Family is the 4th biggest brand in the world. With 350+ hours of top quality Royal content, refreshed monthly and with exclusive commissions, True Royalty curates relevant titles according to Royal news and the viewer's interest areas—British Royals, World Royals, and Royalty through history. There are 25 million people in the US alone who identify as both active Royal fans and who stream on-demand TV, up almost 300% from 8.6 million in 2018. The founders of the channel have assembled a diverse team of proven experts in TV production and distribution, digital marketing, PR, and brand partnerships from around the world. With the investment, the channel has identified partners for further growth opportunities including launching beyond the current US, Canada, Australia, NZ, UK & Ireland into India, Europe, the Middle East, and the Far East demographics.
days to go:
Expired
investment:
£2,148,699
Blind Cupid (BC) is a disruptive personal matchmaker that uses systematic philosophy and Artificial Intelligence (AI) to help users find their long-term partners with the very first match. It does this by asking its users high-quality, short, and introspective questions that reveal what the company calls a user's ‘Sense of life’. The AI system then comes up with potential matches by analysing the above data along with the user's communication style. BC asserts that the global matchmaking market has 91 million users and is currently worth £4.65 billion (2020) with a projected value of £7.68 billion by 2026. It argues that 4 out of 5 beta users met their potential partner on its portal. The company aims to patent its AI and licence it out to eager organisations. It will use the investment to offer investors the opportunity to be a part of the next generation of matchmaking and artificial intelligence.
days to go:
Expired
investment:
£354,989
paus is an on-demand streaming service. It offers specialist, hand-picked independent films to today's streamers who wish to avail a niche streaming service in 2020. The company aims to propel curated independent cinema into the $161 billion global streaming market by replacing conventional subscription and ad-based models with a peer-to-peer digital tipping model. paus is working with globally recognised film institutions to procure curated content. Over 1,900 people have signed up for early access to its iOS app. The company is currently rolling out a beta iOS version in the UK and US. It will use the investment to move into streaming theatre and web-series on its portal.
days to go:
Expired
investment:
£352,724
RheEnergise is an energy company that plans to transform pumped hydro technology and boost its capacity with its patented High-Density Hydro (HDH) technology. The company asserts that, by installing HDH on smaller hills and combining it with its HD Fluid R-19, businesses could produce 2.5 times the energy compared to low-density pumped-hydro. RheEnergise aims to install multiple HDH projects to meet the UK's growing energy needs. The company has agreements with entities like SSE, WelshPower, GreenCat Renewables and REG-Power. It is currently using its funding grants of ~£270,000 over the next nine months to build a defendable "Moat" of IP (Patents, Design and copyrights, know-how, and trade secrets) across six critical integrated sub-systems. The company will use the investment received to hire key personnel, progress patents, and accelerate its activities.
days to go:
Expired
investment:
£850,000
Docandu is an innovative digital health platform designed both for patients & doctors, making digital healthcare accessible from anywhere. Docandu aims to be a key tech health service provider, starting from Greece, improving the existing national and private health care services. The global digital health market is estimated to be worth $536 Billion by 2025. To date, they have developed two separate apps for doctors and patients. They have also received an angel investment of 100,000 Euros and sponsorship of $25,000 from Microsoft. The company has initiated early-stage relationships with a couple of Greek public and private health entities. With the proceeds, they will execute their go-to-market strategy and make global health ID a reality, by expanding its affiliate network of doctors, health providers and public health systems.
days to go:
Expired
investment:
£70,900
